Product News

Forest Laboratories and Cypress Bioscience launched Savella, a selective serotonin and norepinephrine dual reuptake inhibitor, for fibromyalgia. The product will be available in drug stores April 28.

 

Sanofi-Aventis launched Apidra SoloSTAR, an insulin pen, indicated for adults and children 4 years and older, with type 1 diabetes or adults with type 2 diabetes.

You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.